Article Text

Download PDFPDF

Complex interactions in complex traits: obesity and asthma
  1. K G Tantisira,
  2. S T Weiss
  1. Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
  1. Professor S T Weiss

Statistics from Altmetric.com

Introductory article

Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study

B Stenius-Aarniala, T Poussa, J Kvarnstrom, E L Gronlund, M Ylikahri, P Mustajoki

Objective: To investigate the influence of weight reduction on obese patients with asthma. Design: Open study, two randomised parallel groups. Setting: Private outpatients centre, Helsinki, Finland. Participants: Two groups of 19 obese patients with asthma (body mass index (kg/m2) 30 to 42) recruited through newspaper advertisements. Intervention: Supervised weight reduction programme including 8 week very low energy diet. Main outcome measures: Body weight, morning peak expiratory flow (PEF), forced vital capacity (FVC), forced expiratory volume in one second (FEV1); and also asthma symptoms, number of acute episodes, courses of oral steroids, health status (quality of life). Results: At the end of the weight reducing programme, the participants in the treatment group had lost a mean of 14.5% of their pretreatment weight, the controls 0.3%. The corresponding figures after one year were 11.3% and a weight gain of 2.2%. After the 8 week dieting period the difference in changes in percentage of predicted FEV1from baseline in the treatment and control groups was 7.2% (95% confidence interval 1.9% to 12.5%, P=0. 009). The corresponding difference in the changes in FVC was 8.6% (4. 8% to 12.5%, P<0.0001). After one year the differences in the changes in the two groups were still significant: 7.6% for FEV1 (1. 5% to 13.8%, P=0.02) and 7.6% for FVC (3.5% to 11.8%, P=0.001). By the end of the weight reduction programme, reduction in dyspnoea was 13 mm (on a visual analogue scale 0 mm to 100 mm) in the treatment group and 1 mm in the control group (P=0.02). The reduction of rescue medication was 1.2 and 0.1 doses respectively (P=0.03). After one …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.